4.7 Article

Interaction of Purinergic P2X4 and P2X7 Receptor Subunits

Journal

FRONTIERS IN PHARMACOLOGY
Volume 8, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2017.00860

Keywords

P2X7; P2X4; voltage clamp; fluorescence; FRET; interaction; subunit

Funding

  1. Deutsche Forschungsgemeinschaft [Ma1581/15-3, Schm536/9-3]

Ask authors/readers for more resources

P2X4 and P2X7 are members of the P2X receptor family, comprising seven isoforms (P2X1-P2X7) that form homo-and heterotrimeric non-specific cation channels gated by extracellular ATP. P2X4 and P2X7 are widely coexpressed, particularly in secretory epithelial cells and immune and inflammatory cells, and regulate inflammation and nociception. Although functional heteromerization has been established for P2X2 and P2X3 subunits expressed in sensory neurons, there are contradictory reports regarding a functional interaction between P2X4 and P2X7 subunits. To resolve this issue, we coexpressed P2X4 and P2X7 receptor subunits labeled with green (EGFP) and red (TagRFP) fluorescent proteins in Xenopus laevis oocytes and investigated a putative physical interaction between the fusion proteins by Forster resonance energy transfer (FRET). Coexpression of P2X4 and P2X7 subunits with EGFP and TagRFP located in the extracellular receptor domains led to significant FRET signals. Significant FRET signals were also measured between C-terminally fluorophore-labeled full-length P2X41 384 and C-terminally truncated fluorescent P2X71 408 subunits. We furthermore used the two-electrode voltage clamp technique to investigate whether human P2X4 and P2X7 receptors (hP2X4, hP2X7) functionally interact at the level of ATP-induced whole-cell currents. Concentration-response curves and effects of ivermectin (P2X4-potentiating drug) or BzATP (P2X7-specific agonist) were consistent with a model in which coexpressed hP2X4 and hP2X7 do not interact. Similarly, the effect of adding specific inhibitors of P2X4 (PSB-15417) or P2X7 (oATP, A438079) could be explained by a model in which only homomers exist, and that these are blocked by the respective antagonist. In conclusion, we show that P2X4 and P2X7 subunits can form heterotrimeric P2X4/P2X7 receptors. However, unlike observations for P2X2 and P2X3, coexpression of P2X4 and P2X7 subunits does not result in a novel electrophysiologically discriminable P2X receptor phenotype.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

The impact of inosine on hippocampal synaptic transmission and plasticity involves the release of adenosine through equilibrative nucleoside transporters rather than the direct activation of adenosine receptors

Pedro Valada, Sonja Hinz, Christin Vielmuth, Catia R. Lopes, Rodrigo A. Cunha, Christa E. Mueller, Joao Pedro Lopes

Summary: Inosine has neuroprotective effects by indirectly modifying the activity of adenosine receptors and controlling synaptic transmission and plasticity. It acts as a ligand of adenosine receptors with low affinity and shows higher affinity towards the rat A(3) receptor. The impact of inosine on synaptic transmission and plasticity is mediated by modification of extracellular levels of adenosine through equilibrative nucleoside transporters.

PURINERGIC SIGNALLING (2023)

Article Chemistry, Medicinal

Design, synthesis, and structure-activity relationships of diindolylmethane derivatives as cannabinoid CB2 receptor agonists

Andhika B. B. Mahardhika, Anastasiia Ressemann, Sarah E. E. Kremers, Mariana S. Gregorio S. Castanheira, Clara T. T. Schoeder, Christa E. E. Mueller, Thanigaimalai Pillaiyar

Summary: The study synthesized a series of DIM derivatives and evaluated their affinities and efficacies for human CB receptor subtypes. The compound di-(4-cyano-1H-indol-3-yl)methane showed the highest potency as a CB2 receptor agonist and has potential as a novel drug for inflammatory diseases.

ARCHIV DER PHARMAZIE (2023)

Article Pharmacology & Pharmacy

Imaging of Gαq Proteins in Mouse and Human Organs and Tissues

Jan H. Voss, Haneen Al-Hroub, Robin Gedschold, Jennifer M. Dietrich, Evelyn Gaffal, Marieta Toma, Stefan Kehraus, Gabriele M. Koenig, Peter Brust, Bernd K. Fleischmann, Daniela Wenzel, Winnie Deuther-Conrad, Christa E. Mueller

Summary: G protein is identified as a potential drug target for treating complex diseases. The development of specific radiotracers allows for disease diagnosis and research.

PHARMACEUTICS (2023)

Article Biochemistry & Molecular Biology

Synthesis and structure-activity relationships of ticlopidine derivatives and analogs as inhibitors of ectonucleotidase CD39

Chunyang Bi, Laura Schaekel, Salahuddin Mirza, Katharina Sylvester, Julie Pelletier, Sang -Yong Lee, Thanigaimalai Pillaiyar, Jean Sevigny, Christa E. Mueller

Summary: Ticlopidine is an antithrombotic prodrug that inhibits platelet function by covalently blocking the P2Y12 receptor on thrombocytes. It was found that Ticlopidine also inhibits CD39, an enzyme involved in ATP hydrolysis. In this study, a comprehensive analysis of Ticlopidine derivatives was conducted, leading to the discovery of benzotetrahydropyridines as a novel class of allosteric CD39 inhibitors.

BIOORGANIC CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Novel GPR18 Ligands in Rodent Pharmacological Tests: Effects on Mood, Pain, and Eating Disorders

Malgorzata Frankowska, Karolina Wydra, Agata Suder, Magdalena Zaniewska, Dawid Gawlinski, Joanna Miszkiel, Anna Furgala-Wojas, Kinga Salat, Malgorzata Filip, Christa E. Mueller, Katarzyna Kiec-Kononowicz, Magdalena Kotanska

Summary: This study discovered three novel selective ligands for GPR18, including one agonist and two antagonists. The activation of GPR18 has similar effects to the CB receptor system, impacting emotional behavior, food intake, and pain activity. Therefore, GPR18 represents a potential therapeutic target for mood, pain, and/or eating disorders.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Editorial Material Chemistry, Medicinal

Virtual Special Issue: New Drug Modalities in Medicinal Chemistry, Pharmacology, and Translational Science

Jeffrey Aube, Craig W. Lindsley, Christa E. Mueller

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Molecular Taphonomy of Heme: Chemical Degradation of Hemin under Presumed Fossilization Conditions

Mariam Tahoun, Marianne Engeser, Luca Svolacchia, Paul Martin Sander, Christa E. E. Mueller

Summary: This study investigates the stability and degradation of the oxygen-complexing prosthetic group of hemoglobin, heme, under various conditions expected to occur during fossilization. The results reveal that heme is most stable under anaerobic reductive conditions and least stable in the presence of H2O2. The presence of oxygen and H2O2 leads to the cleavage of heme and the formation of hematinic acid. The role of iron cation in heme degradation is confirmed, as heme lacking iron remains more stable. This study provides valuable insights into the fate of heme during fossilization.

MOLECULES (2023)

Editorial Material Chemistry, Medicinal

Virtual Special Issue: New Drug Modalities in Medicinal Chemistry, Pharmacology, and Translational Science

Jeffrey Aube, Craig W. Lindsley, Christa E. Mueller

ACS MEDICINAL CHEMISTRY LETTERS (2023)

Article Multidisciplinary Sciences

Structure-affinity and structure-residence time relationships of macrocyclic Gαq protein inhibitors

Jan H. Voss, Max Cruesemann, Christian R. O. Bartling, Stefan Kehraus, Asuka Inoue, Gabriele M. Koenig, Kristian Stromgaard, Christa E. Mueller

Summary: This study investigated the inhibitory effects of macrocyclic depsipeptides YM-254890 and FR900359 on Gaq/11 proteins and observed significant differences in dissociation kinetics between these compounds and their hydrogenated, tritium-labeled derivatives. Results showed that small structural modifications had a major impact on the residence time of the macrocyclic depsipeptides. FR exhibited pseudo-irreversible binding, while YM had a faster dissociation rate. The isopropyl anchor in FR and some derivatives was found to be essential for slow dissociation. These findings provide a basis for future drug design strategies to modulate residence times of macrocyclic Gq protein inhibitors, which play a crucial role in therapeutic outcomes.

ISCIENCE (2023)

Article Chemistry, Multidisciplinary

Crystal structure of adenosine A2A receptor in complex with clinical candidate Etrumadenant reveals unprecedented antagonist interaction

Tobias Claff, Jonathan G. Schlegel, Jan H. Voss, Victoria J. Vaassen, Renato H. Weisse, Robert K. Y. Cheng, Sandra Markovic-Mueller, Denis Bucher, Norbert Straeter, Christa E. Mueller

Summary: The authors report the crystal structures of A(2A)AR in complex with Etrumadenant, revealing a previously unknown interaction. These findings have implications for the design of selective receptor antagonists.

COMMUNICATIONS CHEMISTRY (2023)

Editorial Material Chemistry, Medicinal

Virtual Special Issue: New Drug Modalities in Medicinal Chemistry, Pharmacology, and Translational Science

Jeffrey Aube, Craig W. Lindsley, Christa E. Mueller

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2023)

Article Biochemistry & Molecular Biology

Xanthine-Dopamine Hybrid Molecules as Multitarget Drugs with Potential for the Treatment of Neurodegenerative Diseases

Michal Zaluski, Tadeusz Karcz, Anna Drabczynska, Christin Vielmuth, Agnieszka Olejarz-Maciej, Monika Gluch-Lutwin, Barbara Mordyl, Agata Siwek, Grzegorz Satala, Christa E. Muller, Katarzyna Kiec-Kononowicz

Summary: Multitarget drugs designed with a hybrid dopamine-xanthine core have potential as drug candidates for neurodegenerative diseases. Further development of monoamine oxidase B (MAO-B) inhibitors with A(2A) adenosine receptor (A(2A)AR) antagonistic properties led to additional phosphodiesterase-4 and -10 (PDE4/10) inhibition and/or dopamine D-2 receptor (D2R) agonistic activity. The compounds showed MAO-B inhibition combined with A(2A)AR affinity, and some compounds exhibited enhanced PDE-inhibitory and D2R-agonistic activity through structural modifications. The multitarget drugs also demonstrated antioxidant properties in vitro and neuroprotective effects in a cellular model.

BIOMOLECULES (2023)

Article Biochemistry & Molecular Biology

Cell Type-Specific Anti-Viral Effects of Novel SARS-CoV-2 Main Protease Inhibitors

Nina Geiger, Viktoria Diesendorf, Valeria Roll, Eva-Maria Koenig, Helena Obernolte, Katherina Sewald, Julian Breidenbach, Thanigaimalai Pillaiyar, Michael Guetschow, Christa E. Mueller, Jochen Bodem

Summary: Recently, we investigated novel pyridyl indole esters and peptidomimetics as potent inhibitors of SARS-CoV-2 main protease. We analyzed the impact of these compounds on viral replication and found that their effectiveness varied in different cell lines. In Huh-7 cells, the protease inhibitors suppressed viral replication by up to 5 orders of magnitude, while in Calu-3 cells, suppression by 2 orders of magnitude was achieved. Three pyridin-3-yl indole-carboxylates showed antiviral activity in all cell lines and also in human precision-cut lung slices.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Chemistry, Medicinal

Discovery of Potent Agonists for the Predominant Variant of the Orphan MAS-Related G Protein-Coupled Receptor X4 (MRGPRX4)

Daniel Marx, Mohamed Wessam Alnouri, Sophie Clemens, Robin Gedschold, Yvonne Riedel, Ghazl Al Hamwi, Thanigaimalai Pillaiyar, Jorg Hockemeyer, Vigneshwaran Namasivayam, Christa E. Mueller

Summary: This study discovered a xanthine derivative that activates the main variant of MRGPRX4, and optimization resulted in analogs with high potency and metabolic stability. These compounds are promising tool compounds for exploring the potential of MRGPRX4 as a future drug target.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Meeting Abstract Immunology

CD73-mediated adenosine production by T cell-derived extracellular vesicles constitutes an intrinsic mechanism of immune suppression

R. Winzer, E. Schneider, A. Rissiek, I. Ricklefs, S. Brenna, B. Rissiek, C. E. Mueller, E. Tolosa

EUROPEAN JOURNAL OF IMMUNOLOGY (2022)

No Data Available